Analyses of Potential Predictive Markers and Survival Data for a Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analyses of Potential Predictive Markers and Survival Data for a Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 9, Pages e76386
Publisher
Public Library of Science (PLoS)
Online
2013-09-28
DOI
10.1371/journal.pone.0076386
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation
- (2013) Iori Sakai et al. BJU INTERNATIONAL
- Vascularity of primary and metastatic renal cell carcinoma specimens
- (2013) Saadia A Aziz et al. Journal of Translational Medicine
- Identifying Resistance Mechanisms against Five Tyrosine Kinase Inhibitors Targeting the ERBB/RAS Pathway in 45 Cancer Cell Lines
- (2013) Zsófia Pénzváltó et al. PLoS One
- Differential Expression of Prognostic Proteomic Markers in Primary Tumour, Venous Tumour Thrombus and Metastatic Renal Cell Cancer Tissue and Correlation with Patient Outcome
- (2013) Alexander Laird et al. PLoS One
- How to select amongst available options for the treatment of advanced RCC?
- (2012) B. Escudier et al. ANNALS OF ONCOLOGY
- CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC
- (2012) Swethajit Biswas et al. CARCINOGENESIS
- C-reactive protein as a prognostic marker for advanced renal cell carcinoma treated with sunitinib
- (2012) Tetsuo Fujita et al. INTERNATIONAL JOURNAL OF UROLOGY
- Predictive factors for response to treatment in patients with advanced renal cell carcinoma
- (2012) Carolina Muriel López et al. INVESTIGATIONAL NEW DRUGS
- Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment
- (2012) Viktor Grünwald et al. OncoTargets and Therapy
- Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma
- (2011) Petri Bono et al. ACTA ONCOLOGICA
- Immunoexpression Status and Prognostic Value of mTOR and Hypoxia-Induced Pathway Members in Primary and Metastatic Clear Cell Renal Cell Carcinomas
- (2011) Luciana Schultz et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma
- (2011) A. J. Zurita et al. ANNALS OF ONCOLOGY
- Clinical efficacy and prognostic factors for overall survival in Japanese patients with metastatic renal cell cancer treated with sunitinib
- (2011) Takeshi Yuasa et al. BJU INTERNATIONAL
- Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib
- (2011) Jenny J. Kim et al. CANCER
- Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
- (2011) Maxine Sun et al. EUROPEAN UROLOGY
- Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
- (2011) B. I. Rini et al. JNCI-Journal of the National Cancer Institute
- Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study
- (2011) Jesus Garcia-Donas et al. LANCET ONCOLOGY
- Survivin promotes glioma angiogenesis through vascular endothelial growth factor and basic fibroblast growth factor in vitro and in vivo
- (2011) Peng Wang et al. MOLECULAR CARCINOGENESIS
- VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin
- (2011) Michelle J. Nyhan et al. CELLULAR ONCOLOGY
- New Strategies in Kidney Cancer: Therapeutic Advances through Understanding the Molecular Basis of Response and Resistance
- (2010) B. I. Rini CLINICAL CANCER RESEARCH
- Genetic Polymorphisms Associated with a Prolonged Progression-Free Survival in Patients with Metastatic Renal Cell Cancer Treated with Sunitinib
- (2010) A. A. M. van der Veldt et al. CLINICAL CANCER RESEARCH
- Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance
- (2010) Yu Lei et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas
- (2010) Bernard Paule et al. PLoS One
- Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart review
- (2009) Toni K. Choueiri et al. BJU INTERNATIONAL
- Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma
- (2009) J-J Patard et al. BRITISH JOURNAL OF CANCER
- CD147 and VEGF Expression in Advanced Renal Cell Carcinoma and Their Prognostic Value
- (2009) Yu-Xiang Liang et al. CANCER INVESTIGATION
- Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma
- (2009) A. C. Young et al. CLINICAL CANCER RESEARCH
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of copy number alterations and its association with pathological features in clear cell and papillary RCC
- (2008) Daisuke Matsuda et al. CANCER LETTERS
- Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma
- (2008) Jean-Jacques Patard et al. INTERNATIONAL JOURNAL OF CANCER
- Antitumor Activity and Biomarker Analysis of Sunitinib in Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now